Manulife (Manufacturers Life Insurance)’s Sionna Therapeutics SION Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.58M Sell
64,458
-4,966
-7% -$190K ﹤0.01% 1399
2025
Q4
$2.87M Buy
69,424
+37,344
+116% +$1.42M ﹤0.01% 1385
2025
Q3
$943K Sell
32,080
-5,958
-16% -$130K ﹤0.01% 1881
2025
Q2
$660K Buy
38,038
+4,489
+13% +$58.8K ﹤0.01% 2033
2025
Q1
$351K Buy
+33,549
New +$548K ﹤0.01% 2289

Other funds holding SION

Manulife (Manufacturers Life Insurance)'s SION Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Sionna Therapeutics (SION) stake by 7.2% in Q1 2026, selling an estimated $190K and leaving 64,458 shares worth $2.58M. The position accounts for ﹤0.01% of the portfolio, ranked #1399.

Manulife (Manufacturers Life Insurance) first reported a position in SION in Q1 2025 and has held it in 5 quarters since. The position peaked at $2.87M in Q4 2025. 122 funds tracked by Wall St. Rank hold SION as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 64,458 shares of Sionna Therapeutics worth $2.58M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 4,966 Sionna Therapeutics shares in Q1 2026, an estimated $190K.
  • Sionna Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1399 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Sionna Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Sionna Therapeutics position peaked at $2.87M in Q4 2025.
  • 122 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.